chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 01-JUL-2015 and 03-JUL-2015, the patient was vaccinated with improperly stored dose of MMR II lot # K016154 with exp. 24-AUG-2016, (route and dose were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
an exacerbation of an underlying back issue; an exacerbation of an underlying back issue; felt it in his opposite shoulder; felt it in his opposite shoulder and jaw.; This is a spontaneous report from a contactable consumer reporting for himself  A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) on 15Feb2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history included an unspecified back issue. Concomitant medications were not reported. On an unspecified date after vaccination patient reported an exacerbation of an underlying back issue. He also felt it in his opposite shoulder and jaw. At the time of the reporting events outcome was unknown.    Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a pharmacist refers to an 18 year old female patient. Patient was not pregnant. The patient's concurrent conditions and medical history were not reported. The patient had completed her childhood M-M-R II series. Upon entering college, the patient was vaccinated with an additional dose of M-M-R II (dose, route, lot number and frequency were not reported). Concomitant medications were not reported. On an unknown date, after her additional dose, the patient's titer levels were low (unspecified lab test was performed). The reporter stated that they were less than one. Patient sought medical attention and contacted pharmacist. No treatment was given for the event. The outcome of the event was unknown. The reporter did not provide the relatedness of the event with M-M-R II. Additional information has been requested.
This spontaneous report as received from a consumer refers to her 67 year old mother. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On 16-JAN-2018, the patient was vaccinated with PNEUMOVAX 23 (dose, route, lot number and expiration date were not reported) for prophylaxis. On the same date, the patient experienced severe chills. The outcome of chills was reported as not recovered. The causal relationship between the event and PNEUMOVAX 23 was not reported.
Information has been received concerning a 14 year old female who on 26-JUN-2007 was vaccinated with a 0.5 ml first dose of Gardasil. On 27-JUN-2007 was vaccinated with a 0.5 ml first dose of Gardasil. On 27-JUN-2007 the patient called the office complaining that her left lung was hurting. On 28-JUN-2007 the patient called the office reporting that she had hives. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Couldn't talk; Very nauseated; Could not stand; Not able to eat; Chills; Severe body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (Could not stand), FEEDING DISORDER (Not able to eat), SPEECH DISORDER (Couldn't talk), CHILLS (Chills) and MYALGIA (Severe body ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 15-Dec-2020 and Breast operation (breast cancer taken off last July). Concurrent medical conditions included Alcohol allergy.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced CHILLS (Chills), MYALGIA (Severe body ache) and HEADACHE (Headache). On 27-Mar-2021, the patient experienced DYSSTASIA (Could not stand) and FEEDING DISORDER (Not able to eat). On 29-Mar-2021, the patient experienced NAUSEA (Very nauseated). On an unknown date, the patient experienced SPEECH DISORDER (Couldn't talk). At the time of the report, DYSSTASIA (Could not stand), FEEDING DISORDER (Not able to eat), SPEECH DISORDER (Couldn't talk), CHILLS (Chills), MYALGIA (Severe body ache), HEADACHE (Headache) and NAUSEA (Very nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided. No Treatment information was provided.
Pt c/o acute abdominal pain then syncope with decreased body temp (95). In ER, LP and bloodwork concerning for shock, no infection found. Stayed in PICU overnight then regular room. Recovered quickly with IV Cleared by GI/Genetics. 9/22/09 Medical office note received DOS 6/08 to 6/09. Hospitalized after DTaP. Reflux, stomach aches. 10/28/2009 Medical records, discharge summary and ICD9 codes received for DOS 12/21/08 (discharge date not provided on record). FINAL DX: Hypothermia, abdominal pain, chronic, vomiting, constipations. Child admitted after acute episode of abdominal pain, lethargy, vomiting and hypothermia. Temp upon admit 33c rectal. WBC increased. Blood sugar borderline hypoglycemic.  Acidotic per gases. PICU for observation then to general ward thereafter. Blood, urine and CSF cx neg.  ABX d/c due to concern for metabolic disorder. Influenza neg. Thyroid WNL. CT head neg.  Upon discharge temp WNL. Active and playful. Back to baseline. Discharged to home. Follow-up endocrine/GI.  ICD9 CODES: 991.6, 789.0, 787.03, 564. 0, 780.63, 285.9, 276. 51, 251.2, 780.65, 564.09, 276.2, 338.29, 789.05  12/21/09 DC summary and hospital records received for dates 12/21/08.  DX: hypothermia, abdominal pain, vomiting, constipation. Pt was admitted for acute episode of vomit and diaphoresis w/ temp 94-95F. Pt found to be acidotic, borderline hypoglycemic. Pt stable at dc.
heart arrhythmia; hypokalemic, low in potassium; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose  via an unspecified route of administration, administered in Arm Left on 17Apr2021 at age of 43-year-old (Lot Number: EW0162) at single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included bupropion hydrochloride (WELLBUTRIN XL). The patient previously took first dose of bnt162b on 26Mar2021 (lot number: ER8732) for COVID-19 immunization and experienced heart arrhythmia. After the second vaccine in Apr2021, it exponentially increased to the point that she was in the emergency room (ER), the patient was laying flat on the floor and as soon as I get out the arrhythmia started. On an unspecified date in Apr2021 night they were testing and it was arrhythmia. She didn't know if it is related to the vaccine or not but she did not have arrhythmia beforehand and a friend of the patient mentioned that she should call it in.  She underwent many lab tests in Apr2021 because she was in the ER. The lab results showed that she was hypokalemic, low in potassium other then that everything came back fairly normal. The patient was on treatment for arrhythmia on 29Apr2021. The outcome of the events was unknown.
lymph node is painful; lymph node size increased; rash all around the injection site; injection site, hot to touch.; huge lymph node, in the same arm of the injection; dizziness; throwing out; super tiredness; injection arm soreness (right arm); This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VOMITING (throwing out), FATIGUE (super tiredness), PAIN IN EXTREMITY (injection arm soreness (right arm)) and LYMPHADENOPATHY (huge lymph node, in the same arm of the injection) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced DIZZINESS (dizziness), VOMITING (throwing out), FATIGUE (super tiredness) and PAIN IN EXTREMITY (injection arm soreness (right arm)). On 30-Apr-2021, the patient experienced LYMPHADENOPATHY (huge lymph node, in the same arm of the injection). On 02-May-2021, the patient experienced LYMPH NODE PAIN (lymph node is painful), LYMPHADENITIS (lymph node size increased), VACCINATION SITE RASH (rash all around the injection site) and VACCINATION SITE WARMTH (injection site, hot to touch.). At the time of the report, DIZZINESS (dizziness), VOMITING (throwing out), FATIGUE (super tiredness), PAIN IN EXTREMITY (injection arm soreness (right arm)), LYMPHADENOPATHY (huge lymph node, in the same arm of the injection), LYMPH NODE PAIN (lymph node is painful), LYMPHADENITIS (lymph node size increased), VACCINATION SITE RASH (rash all around the injection site) and VACCINATION SITE WARMTH (injection site, hot to touch.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Client developed pain and swelling five hours after receiving Pneumonia vaccine in the left shoulder and arm.  Shoulder is warm to touch.
Don't recall any reaction other than the blood clot. It was 2 days after my leg got very hot and discolored and very tender in the right leg above knee. Saw the doctor on Monday on 22 Feb2021.
wanted to report that is pregnant and received the vaccine; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (wanted to report that is pregnant and received the vaccine) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 22-Apr-2021. On 08-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (wanted to report that is pregnant and received the vaccine). On 08-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (wanted to report that is pregnant and received the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.; Reporter's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 29-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy
Patient was to receive DTAP-Infanrix and instead received DTAP/HEP B/IPV-Pediarix. This error was caught by the system when the lot number did not match what this nurse wrote on the paper and submitted to the front desk for processing. It was at that time that the error was found. Patient was still in the clinic and assessed without any problems. Mom was notified at that time.
Two days after my second vaccination, a cluster of shingles blisters appeared on my nose.  A few days later, more blisters appeared on my chin, and two days after that, another cluster appeared on my forehead. I'd had shingles before, most recently in November 2018, and didn't make any connection to the vaccine until I read a report about shingles in post-vaccinated individuals with rheumatoid arthritis in a study. My brother, a doctor  working on Covid control and immunization suggested I report it.
This spontaneous report as received from a other health professional refers to a pediatric patient of unknown age. On 06-JUL-2011 the patient was vaccinated with first dose of RECOMBIVAX HB 5 MCG/0.5 ML, 0.5 ml, intramuscular. Other doses RECOMBIVAX HB were given respectively on 06-SEP-2011 (second dose), 06-FEB-2012 (third dose), 2013 (4th dose). The patient received 4 doses of RECOMBIVAX HB. No adverse effect reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
I developed shingles five days ago I?m completely healthy with no health problems not a diabetic I exercise moderately I know no health issues
I received my Covid-19 vaccine on 09/09/2022. I was diagnosed with PMR since having a pain with neck shoulder and hips. I was also diagnosed with Covid 03/01/2023. I was having congestion and sinus issues.
25 min after vaccine injection, symptoms included nausea, headache, a lightheadedness. 20 min after onset of symptoms she stated feeling better when lying down although still had a headache. An hr later continued to have a headache and nausea and it was reported she had slurred speech. Was released to go home and advised to cal HCP.
tiredness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program from a Corporate (Pfizer) Social Media Platforms. The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "recovered", described as "tiredness". Additional information: all the patient felt was a little tiredness an hour after the first shot took a nap everything was good.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Was given on 12-14-16 and was in office due to redness from elbow to clavicle on 12-16-16. Pediatric I.D. was notified, advised to start Clindamycin and BENADRYL. Pt was seen 12-17-16 and less redness.
CLIENT STATES BURNING OF TONGUE TWO DAYS AFTER RECEIVING IMOVAX.
Swelling in left arm, redness, lethargy, severe chills, severe pain in left bicep, inability to lift left arm.
Gestational hypertension in third trimester developing into severe preeclampsia, blood pressure climbed in the weeks before delivery and reached max of approximately 180/110 First pregnancy Baby was breech, delivered by c-section one day short of 37 weeks, birth weight 6 lb 0.05 oz Baby with very minor hypospadias and hydrocele in testicle, otherwise healthy
This spontaneous report as received from a nurse practitioner via company representative refers to a patient of unknown age and gender. The patient's medical history was not reported. In approximately April 2012 (reported as about 4 years ago), the patient as vaccinated with a dose of ZOSTAVAX (lot #, expiration date, dose, route and site of administration were not reported) and an unspecified flu vaccine. On an unknown date, the patient experienced a twitch in her eye. The outcome of twitch in eye was unknown. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
17OCT93 pt noted a 1 1/2 diameter lump @ inject site; 18OCT it was up to 3" & red on 19OCT93 site was red non tender;
Began with dizziness within 3 hours of shot. Then headache, stiff neck, sore arm.  Took Acetaminophen.  Next day: bad headache, body aches, very sore arm, occasional dizziness, nausea, sweating, feeling faint.  Exhausted! Took Acetaminophen and slept.  Second day: feeling like a truck hit me. Was beginning to feel like I was having an RA and fibromyalgia flare up x 10!  Low-grade temp 99.5 and exhaustion. More Acetaminophen, Flexeril , heat packs and sleep.  Third day: fever gone, body aches gone, feeling much better.
On 4/6/2020 At 9:00 AM I was feeding my son and his arms along with his head began to shake for 15 seconds.   On 4/7/2020 - 04/8/2020, the same thing happened around 12 PM while I was feeding him. It lasted 10-15 seconds   On 04/08/2020 around 3 pm he was sitting while playing and his head/both arms began to shake.   On 04/12/2020 during feeding around 12 pm the same thing happened.
felt weak; Felt shaky; This case was reported by a physician via sales rep and described the occurrence of feelings of weakness in a female patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received the 1st dose of Bexsero. On an unknown date, couple of hours after receiving Bexsero, the patient experienced feelings of weakness and shaky feelings. On an unknown date, the outcome of the feelings of weakness and shaky feelings were recovered/resolved.   It was unknown if the reporter considered the feelings of weakness and shaky feelings to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, the patient's parent indicated that the patient felt weak and shaky. The reporter thought the symptoms were too soon after the vaccination to be related to the vaccine and ultimately the symptoms resolved with no additional issue.
The evening after vaccination child developed redness, warmth and swelling measuring 7.25 cm horizontally and 9 cm vertically in upper arm where vaccination occured.  The child also had itching and benadryl was given.  Benadryl helped with itching, but the redness, and swelling increased.  Child was seen in office the following morning, 16 hours after first measurement and area of redness, swelling and warmth now measured 12.5 cm vertically and 12.75 cm horizontally.  Plan of care was for Motrin 3 times a day for next two days, and benadryl as needed for itching.  Will plan for further follow-up if increases redness, pain, or changes in sensation occur.
burning at injection site, hard lump approximately the size of a marble for several weeks, chronic fatigue, suddenly developed allergies to 76 different substances (environmental as well as food and pet), onset of migraines
could not stand up after 2nd dose; strong vertigos after 2nd dose; great fatigue after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of DYSSTASIA (could not stand up after 2nd dose), VERTIGO (strong vertigos after 2nd dose) and FATIGUE (great fatigue after 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSSTASIA (could not stand up after 2nd dose), VERTIGO (strong vertigos after 2nd dose) and FATIGUE (great fatigue after 2nd dose). At the time of the report, DYSSTASIA (could not stand up after 2nd dose), VERTIGO (strong vertigos after 2nd dose) and FATIGUE (great fatigue after 2nd dose) outcome was unknown.            Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to CH-MODERNATX, INC.-MOD-2021-154325, CH-MODERNATX, INC.-MOD-2021-154241, CH-MODERNATX, INC.-MOD-2021-155361, CH-MODERNATX, INC.-MOD-2021-155504 (E2B Linked Report).; Sender's Comments:  CH-MODERNATX, INC.-MOD-2021-154325: CH-MODERNATX, INC.-MOD-2021-154241: CH-MODERNATX, INC.-MOD-2021-155361: CH-MODERNATX, INC.-MOD-2021-155504:
Youth given TD on 9/15/00 and 7 minutes, post vax, she complained of itching at site. Site is erythematous about 10cm completely around and is slightly raised. No respiratory symptoms. BP 150/80; HR 92; Resp 18. Youth was given Benadryl IM in right deltoid. At 10:00 BP 124/70; HR 80; Resp 18. Youth states the itching has decreased and erythema is resolving.
SWEAT; DIARRHEA; DIZZINESS; vaccination site pain; This spontaneous case was reported by a health care professional and describes the occurrence of HYPERHIDROSIS (SWEAT), DIARRHOEA (DIARRHEA), DIZZINESS (DIZZINESS) and VACCINATION SITE PAIN (vaccination site pain) in an 80-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CENTRUM ACTIVE, IVERMECTIN and CODEINE PHOSPHATE, PARACETAMOL (TYLENOL WITH CODEINE) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HYPERHIDROSIS (SWEAT), DIARRHOEA (DIARRHEA), DIZZINESS (DIZZINESS) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, HYPERHIDROSIS (SWEAT), DIARRHOEA (DIARRHEA), DIZZINESS (DIZZINESS) and VACCINATION SITE PAIN (vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided
got the flu after getting a flu shot; Initial information was received on 14-Oct-2020 regarding an unsolicited valid non-serious social media case from the patient.  This case was linked to case 2020SA291942 (same reporter).  This case involves an unknown demographic patient who got flu (influenza), after the patient received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), family history and concomitant medication were not reported.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, the patient developed non-serious flu (influenza), (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome was not reported.  There will be no information available on the batch number for this case.
I had chest pain, was achy, very tired, and shortness of breath. My left arm hurt.
Joint pain; Shortness of breath; Very bad chills; This spontaneous case was reported by a patient and describes the occurrence of DYSPNOEA (Shortness of breath), CHILLS (Very bad chills) and ARTHRALGIA (Joint pain) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath) and CHILLS (Very bad chills). On 18-Feb-2021, the patient experienced ARTHRALGIA (Joint pain). At the time of the report, DYSPNOEA (Shortness of breath) had not resolved and CHILLS (Very bad chills) and ARTHRALGIA (Joint pain) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.
I called and they said the booster was available, later on knowing it was not even approved yet they gave me the third shot at full dosage, and about a week after wards i started to notice that I was having heaviness breathing, chest pains, and shortness of breath. This has continued and now I have ended up having surgery and also am on a huge amount of medicine.